Evidence map›Paper›PMID 30613558›Full record

ArticleJournal of family medicine and primary care

Investigating the risk of Incident diabetes mellitus among primary care patients treated with simvastatin in North-Central Trinidad.

Raveed Khan, Arlene Williams, Devon Matthew Dass, Amelia Dan, Rhea-Marie Cunningham, Cherrise Choya, Yan Shao Chen, Atieannah Choucoutou, Cherisse Crawford, Yasmine Cooke

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of family medicine and primary care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Raveed KhanPublic Health and Primary Care Unit, Para Clinical Sciences, The University of the West Indies, Trinidad, W.I, Trinidad and Tobago.
Arlene WilliamsPharmacolofgy Unit, Para Clinical Sciences, The University of the West Indies, Trinidad, W.I, Trinidad and Tobago.
Devon Matthew DassThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Amelia DanThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Rhea-Marie CunninghamThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Cherrise ChoyaThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Yan Shao ChenThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Atieannah ChoucoutouThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Cherisse CrawfordThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
Yasmine CookeThe University of the West Indies, Trinidad, W.I., Trinidad and Tobago.
University of Trinidad and Tobago · TTUniversity of the West Indies · TT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the risk of new-onset diabetes mellitus in patients treated with simvastatin at primary healthcare clinics in North Central Trinidad. MATERIALS AND

methodsA retrospective descriptive case-series study design was applied to 384 conveniently sampled patient medical records from the cluster of primary healthcare centers during the period of February 2016-May 2016. Information from the patient files were then recorded using a systematic data extraction form. The major inclusion criteria were non-diabetic patients who were compliant with daily simvastatin for a minimum period of 1 year. The risk of incident diabetes mellitus was calculated, using SPSS version 20.0. Chi-squared (χ

resultsIn all, 207 patients became diabetic during their treatment period translating into a 53.9% risk of incident diabetes mellitus (χ

conclusionIn this population, simvastatin use is associated with a 53.9% increased risk of development of new-onset diabetes mellitus (χ

Indexed as

Diabetesincident diabetessimvastatinTrinidad

Identifiers

PMID30613558
PMCPMC6293921
OpenAlexW2902842712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.